Literature DB >> 22075544

Kidney stones.

Timothy Y Tseng1, Glenn M Preminger.   

Abstract

INTRODUCTION: The age of peak incidence for stone disease is 20 to 40 years, although stones are seen in all age groups. There is a male to female ratio of 3:2. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions for stone removal in people with asymptomatic kidney stones? What are the effects of interventions for the removal of symptomatic renal stones? What are the effects of interventions to remove symptomatic ureteric stones? What are the effects of interventions for the management of acute renal colic? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2011 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 21 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: antispasmodic drugs, extracorporeal shockwave lithotripsy, intravenous fluids, non-steroidal anti-inflammatory drugs (NSAIDs), opioids, oral fluids, percutaneous nephrolithotomy, and ureteroscopy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075544      PMCID: PMC3275105     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  42 in total

1.  Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association.

Authors:  J W Segura; G M Preminger; D G Assimos; S P Dretler; R I Kahn; J E Lingeman; J N Macaluso
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

2.  Randomized controlled, multicentre clinical trial comparing a dual-probe ultrasonic lithotrite with a single-probe lithotrite for percutaneous nephrolithotomy.

Authors:  Amy E Krambeck; Nicole L Miller; Mitchell R Humphreys; Stephen Y Nakada; John D Denstedt; Hassan Razvi; Glenn M Preminger; Robert B Nadler; Brian R Matlaga; Ryan F Paterson; Ben H Chew; Larry C Munch; Shelly E Handa; James E Lingeman
Journal:  BJU Int       Date:  2010-09-21       Impact factor: 5.588

3.  Tamsulosin to treat uncomplicated distal ureteral calculi: a double blind randomized placebo-controlled trial.

Authors:  Taha A Abdel-Meguid; Abdulmalik Tayib; Ahmad Al-Sayyad
Journal:  Can J Urol       Date:  2010-06       Impact factor: 1.344

4.  Forced versus minimal intravenous hydration in the management of acute renal colic: a randomized trial.

Authors:  W Patrick Springhart; Charles G Marguet; Roger L Sur; Regina D Norris; Fernando C Delvecchio; Matthew D Young; Paula Sprague; Charles A Gerardo; David M Albala; Glenn M Preminger
Journal:  J Endourol       Date:  2006-10       Impact factor: 2.942

5.  Does rate matter? The results of a randomized controlled trial of 60 versus 120 shocks per minute for shock wave lithotripsy of renal calculi.

Authors:  Kim Davenport; Andrea Minervini; Stephen Keoghane; John Parkin; Francis X Keeley; Anthony G Timoney
Journal:  J Urol       Date:  2006-11       Impact factor: 7.450

6.  Oral diclofenac in the prophylactic treatment of recurrent renal colic. A double-blind comparison with placebo.

Authors:  E Laerum; O E Ommundsen; J E Grønseth; A Christiansen; H E Fagertun
Journal:  Eur Urol       Date:  1995       Impact factor: 20.096

7.  Treatment of large impacted proximal ureteral stones: randomized comparison of percutaneous antegrade ureterolithotripsy versus retrograde ureterolithotripsy.

Authors:  Xiaowen Sun; Shujie Xia; Jun Lu; Haitao Liu; Bangmin Han; Weiguo Li
Journal:  J Endourol       Date:  2008-05       Impact factor: 2.942

8.  The case for a more aggressive approach to staghorn stones.

Authors:  J P Blandy; M Singh
Journal:  J Urol       Date:  1976-05       Impact factor: 7.450

9.  Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial.

Authors:  Thomas Hermanns; Peter Sauermann; Kaspar Rufibach; Thomas Frauenfelder; Tullio Sulser; Räto T Strebel
Journal:  Eur Urol       Date:  2009-04-03       Impact factor: 20.096

10.  Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients.

Authors:  Abdulla Al-Ansari; Abdulla Al-Naimi; Abdulkader Alobaidy; Khalid Assadiq; Mohamed D Azmi; Ahmed A Shokeir
Journal:  Urology       Date:  2010-01       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.